IGHJ4 and cancer: Interestingly, while previous studies have shown that IGHJ4 is preferentially utilized across various immune-related conditions, including autoimmune diseases (Hirokawa et al., 2019), cancers (Katsibardi et al., 2011), and infectious diseases (Andreano et al., 2021), our study found a distinct pattern.